Aytu BioScience, Inc. (AYTU): Price and Financial Metrics
AYTU Price/Volume Stats
| Current price | $2.79 | 52-week high | $3.50 |
| Prev. close | $2.79 | 52-week low | $1.38 |
| Day low | $2.74 | Volume | 6,900 |
| Day high | $2.83 | Avg. volume | 19,525 |
| 50-day MA | $3.01 | Dividend yield | N/A |
| 200-day MA | $2.50 | Market Cap | 15.53M |
AYTU Stock Price Chart Interactive Chart >
Aytu BioScience, Inc. (AYTU) Company Bio
Aytu BioScience, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel products in the field of hypogonadism (low testosterone), cough and upper respiratory symptoms, insomnia, and male infertility in the United States and internationally. The company markets Natesto, a nasal gel for the treatment of hypogonadism (low testosterone) in men; and Tuzistra XR, a prescription antitussive consisting of codeine polistirex and chlorpheniramine polistirex in an oral suspension. It also offers ZolpiMist, an oral spray for the treatment of insomnia; and MiOXSYS, an in vitro diagnostic semen analysis test that is used in the measurement of static oxidation reduction potential in human semen. Aytu BioScience, Inc. is based in Englewood, Colorado.
Latest AYTU News From Around the Web
Below are the latest news stories about AYTU BIOPHARMA INC that investors may wish to consider to help them evaluate AYTU as an investment opportunity.
Presenting on the Emerging Growth Conference 65 Day 2 on December 7th Register NowMIAMI, Dec. 06, 2023 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 65th Emerging Growth Conference on December 6th and 7th, 2023. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting |
Aytu BioPharma to Present on the Emerging Growth Conference on December 7, 2023Webcasted presentation to take place at 1:10pm ETDENVER, CO / ACCESSWIRE / November 30, 2023 / Aytu BioPharma, Inc. (the Company or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, today announced that ... |
Aytu BioPharma, Inc. (NASDAQ:AYTU) Q1 2024 Earnings Call TranscriptAytu BioPharma, Inc. (NASDAQ:AYTU) Q1 2024 Earnings Call Transcript November 14, 2023 Aytu BioPharma, Inc. beats earnings expectations. Reported EPS is $-0.00148, expectations were $-0.04. Robert Blum: Good afternoon, everyone, and thank you for joining us for Aytu BioPharma’s Fiscal 2024 First Quarter Financial Results Conference Call for the period ended September 30, 2023. Joining […] |
Aytu BioPharma Reports Fiscal 2024 First Quarter Financial ResultsQ1 2024 Adjusted EBITDA of $2.2 millionRx Segment net revenue of $17.8 million and Adjusted EBITDA of $2.4 million in Q1 2024Q1 2024 ADHD net revenue up 31% compared to Q1 2023$20.0 million cash balance at September 30, 2023Company to host conference ... |
Aytu BioPharma Ranked Among Fastest-Growing Companies in North America on Deloitte's Technology Fast 500(TM) for Third Consecutive YearRanked 118th Fastest Growing Company in North AmericaRanked 23rd Fastest Growing Life Sciences CompanyDENVER, CO / ACCESSWIRE / November 8, 2023 / Aytu BioPharma, Inc. (the Company or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on commercializing ... |
AYTU Price Returns
| 1-mo | -6.38% |
| 3-mo | 10.28% |
| 6-mo | -5.10% |
| 1-year | 3.33% |
| 3-year | -97.94% |
| 5-year | -99.25% |
| YTD | -1.76% |
| 2023 | -24.87% |
| 2022 | -86.00% |
| 2021 | -77.42% |
| 2020 | -38.51% |
| 2019 | 23.10% |
Continue Researching AYTU
Here are a few links from around the web to help you further your research on Aytu Bioscience Inc's stock as an investment opportunity:Aytu Bioscience Inc (AYTU) Stock Price | Nasdaq
Aytu Bioscience Inc (AYTU) Stock Quote, History and News - Yahoo Finance
Aytu Bioscience Inc (AYTU) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...